Skip to main content

Table 1 Demographic and clinical characteristics - ITT population

From: High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids

 

BDP/FF

N = 184

BDP

N = 175

Age (years)

Mean (SD)

49.5 (13.7)

49.1 (14.1)

Gender n (%)

Male

84 (45.7)

63 (36)

Female

100 (54.3)

112 (64)

BMI (kg/m2)

Mean (SD)

26.8 (4.6)

27.1 (5.2)

Smoking n (%)

Non-smoker

151 (82.1)

147 (84)

Ex-smoker

33 (17.9)

28 (16)

Therapy at study entry n (%)

ICS alone

16 (8.7)

15 (8.6)

ICS/LABA

168 (91.3)

160 (91.4)

FEV1 (L)a

Mean (SD)

2.1 (0.6)

1.9 (0.5)

FEV1 % of pred. normal valuea

Mean (SD)

64.7 (8.1)

64.3 (9.5)

Reversibility: FEV1 change (L)b

Mean (SD)

0.53 (0.3)

0.56 (0.3)

Reversibility: FEV1 % changeb

Mean (SD)

27.7 (15.7)

30.2 (19.3)

PEFa

Mean (SD)

310.4 (107.6)

312.6 (102.6)

ACQa

Mean (SD)

2.12 (0.6)

2.12 (0.6)

  1. aMeasured at randomization, bMeasured at screening